Warning: The NCBI web site requires JavaScript to function. more...
Does the drug sensitivity of malaria parasites depend on their virulence?
Schneider P, Chan BH, Reece SE, Read AF.
Malar J. 2008 Dec 16;7:257.
Related citations
Plasmodium chabaudi chabaudi malaria parasites can develop stable resistance to atovaquone with a mutation in the cytochrome b gene.
Afonso A, Neto Z, Castro H, Lopes D, Alves AC, Tomás AM, Rosário VD.
Malar J. 2010 May 21;9:135.
Competitive release of drug resistance following drug treatment of mixed Plasmodium chabaudi infections.
de Roode JC, Culleton R, Bell AS, Read AF.
Malar J. 2004 Sep 14;3:33.
Virulence in rodent malaria: host genotype by parasite genotype interactions.
Mackinnon MJ, Gaffney DJ, Read AF.
Infect Genet Evol. 2002 Jul;1(4):287-96.
Plasmodium chabaudi: effect of antimalarial drugs on gametocytogenesis.
Buckling A, Crooks L, Read A.
Exp Parasitol. 1999 Sep;93(1):45-54.
Host heterogeneity is a determinant of competitive exclusion or coexistence in genetically diverse malaria infections.
de Roode JC, Culleton R, Cheesman SJ, Carter R, Read AF.
Proc Biol Sci. 2004 May 22;271(1543):1073-80.
Fitness of drug-resistant malaria parasites.
Walliker D, Hunt P, Babiker H.
Acta Trop. 2005 Jun;94(3):251-9. Epub 2005 Apr 18. Review.
Virulence and drug resistance in malaria parasites.
Stein WD, Sanchez CP, Lanzer M.
Trends Parasitol. 2009 Oct;25(10):441-3. Epub 2009 Sep 4.
Experimental evaluation of the relationship between lethal or non-lethal virulence and transmission success in malaria parasite infections.
Paul RE, Lafond T, Müller-Graf CD, Nithiuthai S, Brey PT, Koella JC.
BMC Evol Biol. 2004 Sep 8;4:30.
Different responses of three rodent Plasmodia species, Plasmodium yoelii 17XL, P. berghei NK65 and P. chabaudi AS on treatment with febrifugine and isofebrifugine mixture from Hydrangea macrophylla var. Otaksa leaf in ICR mice.
Ishih A, Miyase T, Ohori K, Terada M.
Phytother Res. 2003 Jun;17(6):650-6.
Immunity promotes virulence evolution in a malaria model.
Mackinnon MJ, Read AF.
PLoS Biol. 2004 Sep;2(9):E230. Epub 2004 Jun 22.
Chemotherapy, within-host ecology and the fitness of drug-resistant malaria parasites.
Huijben S, Nelson WA, Wargo AR, Sim DG, Drew DR, Read AF.
Evolution. 2010 Oct;64(10):2952-68. doi: 10.1111/j.1558-5646.2010.01068.x. Epub 2010 Aug 19.
A study on pathogenicity and mosquito transmission success in the rodent malaria parasite Plasmodium chabaudi adami.
Gadsby N, Lawrence R, Carter R.
Int J Parasitol. 2009 Feb;39(3):347-54. Epub 2008 Aug 8.
Virulence and competitive ability in genetically diverse malaria infections.
de Roode JC, Pansini R, Cheesman SJ, Helinski ME, Huijben S, Wargo AR, Bell AS, Chan BH, Walliker D, Read AF.
Proc Natl Acad Sci U S A. 2005 May 24;102(21):7624-8. Epub 2005 May 13.
Within-host competition in genetically diverse malaria infections: parasite virulence and competitive success.
Bell AS, de Roode JC, Sim D, Read AF.
Evolution. 2006 Jul;60(7):1358-71.
The effect of chloroquine treatment on the infectivity of Plasmodium chabaudi gametocytes.
Buckling AG, Read AF.
Int J Parasitol. 1999 Apr;29(4):619-25.
The fitness of drug-resistant malaria parasites in a rodent model: multiplicity of infection.
Huijben S, Sim DG, Nelson WA, Read AF.
J Evol Biol. 2011 Nov;24(11):2410-22. doi: 10.1111/j.1420-9101.2011.02369.x. Epub 2011 Aug 23.
Host-parasite interactions for virulence and resistance in a malaria model system.
Grech K, Watt K, Read AF.
J Evol Biol. 2006 Sep;19(5):1620-30.
Experimental manipulation of immune-mediated disease and its fitness costs for rodent malaria parasites.
Long GH, Chan BH, Allen JE, Read AF, Graham AL.
BMC Evol Biol. 2008 Apr 30;8:128.
Mosquito mortality and the evolution of malaria virulence.
Ferguson HM, Mackinnon MJ, Chan BH, Read AF.
Evolution. 2003 Dec;57(12):2792-804.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on